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Abstract
Background: Relevant information on health research must be made publicly available in an accurate, timely and
accessible manner if evidence is to inform practice and benefit patient care. Failure to publish research information
represents a significant waste of research funds. However, recent studies have demonstrated that non-publication
and selective or biased reporting remains a significant problem. The role of online publications in rectifying these
issues by providing open access to study information is increasingly recognised.
Objective: This paper details a novel approach to publishing research information developed by the National Institute
for Health Research (NIHR), a major funder of health research in the United Kingdom. The NIHR has enhanced
its Journals Library (www.journalslibrary.nihr.ac.uk), providing an online repository of information from research
funded through five programmes. We describe how the NIHR Journals Library provides a ‘thread’ of relevant
information for each study, including protocols, participant information sheets, data linkages, final reports, publications
and diverse knowledge products. We also discuss the Library as a ‘living’ resource, one that is updated as each study
progresses from inception to completion. Finally, we consider the implications of the Library for the NIHR, other journals
and research teams submitting information.
Conclusion: Openly publishing information from funded research in the NIHR Journals Library serves as a model of
knowledge sharing, maximising return on investment and enhancing the usability and replicability of research findings
for different evidence-user communities. The Library also supports wider ‘research on research’ ambitions, enabling
users to interrogate the repository of NIHR-funded studies, enhancing the understanding of research commissioning,
design, dissemination and impact.
Video abstract: www.youtube.com/watch?v=8H03uxN_iTE.
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Background
Research must be published accurately, in full and in a
timely manner if it is to inform practice and benefit
patient care. Failing to make evidence publicly available
in a timely fashion represents a significant waste in re-
search funds and is unethical by limiting impact on pa-
tient care [1–3]. Recent studies have shown that many
studies remain unpublished years after completion and
that a bias towards publishing studies with significant
results remains [2–8]. These factors can lead to an
over-estimation of treatment effect and restricts the
availability of evidence to inform clinical practice and
policy decision-making.
The applicability and replicability of published studies
can be limited by incomplete or biased reporting [1, 9].
For example, descriptions of interventions in published
trials often miss important information such as dose/dur-
ation of the procedure and control group comparators, a
problem that is particularly prevalent in trials of complex
interventions [10–12]. Comparisons of published trials
with protocols or clinical study reports have revealed an
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underreporting of efficacy, adverse events and other
patient-relevant outcomes in journal publications [13–15].
Published clinical trials may be selective in their report-
ing of analyses and outcomes, for example, favouring
statistically significant results, and omitting or switching
primary and secondary outcomes to obtain more
favourable results [15–17]. Whilst reporting guidelines
such as CONSORT, PRISMA and STARD have been de-
signed and implemented to improve the quality and com-
pleteness of reporting, information on study design,
analysis, interventions or outcomes often remains inad-
equate [18–20].
The development of online publications has begun to
rectify these problems, providing opportunities for full
open access of study information [21]. In 1999, Chal-
mers and Altman outlined how electronic resources
could generate an online ‘thread’ of publications, starting
with the protocol, continuing with reports from the
resulting research and culminating with links to the
complete dataset [22]. Online journals, such as Trials,
have subsequently supported the ‘threaded’ concept by
accepting a range of publications, including the protocol,
first report of trial findings, secondary analyses, statis-
tical analysis plans and lessons learned [18]. The Linked
Reports of Clinical Trials project uses the CrossMark
standard to include information about an article such as
the clinical trial number and the trial registry, associat-
ing this information with the article DOI on publication.
This means that queries on the CrossRef database iden-
tify articles related to the clinical trial number [23]. The
OpenTrials initiative extends the Linked Reports of Clin-
ical Trials approach further, establishing a database that
includes not just publications but also other relevant
trial information, including registry entries, sections of
regulatory documents, structured data on methods, clin-
ical study reports, blank consent forms and protocols
[24]. Linking material such as statistical analysis plans,
protocols and trial results in this manner has multiple
benefits, maximising the availability of study information
and enabling assessments of within-study reporting bias
to be made.
Electronic publication also fundamentally challenges
existing concepts of academic publishing, moving away
from the production of a ‘final paper’ to establishing a
single ‘living document source’, containing all relevant
material that is updated as the study progresses [25].
Whilst the ambitions of living documents remain largely
aspirational, they illustrate the potential of electronic
publications [25].
The NIHR Health Technology Assessment (HTA)
programme is a major funder of health research in
response to NHS and health needs and has published
full reports of the research it funds through its own
peer reviewed, freely accessible, online NIHR journal
(www.journalslibrary.nihr.ac.uk/hta) over the past 20
years. Researchers are obliged by contract to publish
in the NIHR’s journal, which has yielded many bene-
fits, including a 98% publication rate, excellent quality
control and full accountability for the use of public
money [26]. Open reporting through the journal sup-
ports the United Kingdom’s departments of health
and social care’s continuing commitment to transpar-
ency in health research, and NIHR’s policy on open
access. In 2013, the NIHR HTA publishing model was
extended to four other programmes, namely Efficacy and
Mechanism Evaluation, Health Services and Delivery
Research, Public Health Research and Programme Grants
for Applied Research, to collectively form the NIHR Jour-
nals Library (NJL; www.journalslibrary.nihr.ac.uk/).
The NJL is widely accessed, with over 230,000 unique
visitors a year worldwide. Programmes fund various
study designs and therefore the NJL covers a wide range
of trials, evidence syntheses, observational studies and
other methodologies. The NJL has recently evolved
further, building on the concepts of threaded publica-
tions. The new NJL brings together, in one freely access-
ible site, all publications, documents and other web
resources relating to NIHR-funded projects, as well as
full reports when published in the online NIHR journals.
The NJL supports living publications by establishing ac-
counts of NIHR studies at their outset and developing
these alongside each study. The new NJL is delivered as
part of wider activity that seeks to maximise the trans-
parency of funded research across the whole of the
NIHR. This paper describes the information contained
in the NJL and how the resource can be accessed by
evidence users.
Developing the archive
The concept of the living, threaded publication was
developed from March 2015 through an iterative, par-
ticipatory process involving NIHR Journals’ editors and
advisory group members, patient and public contribu-
tors, researchers and research customers. We surveyed
users of the NIHR Journals over a 4-month period,
exploring views of the former NJL and identifying what
new features participants would find most useful in the
new site. Key requirements identified included access to
scientific abstracts and plain English summaries, links to
protocols, related project information (e.g. the commis-
sioning brief to which the research was responding, or
related systematic reviews), and other outputs from the
same study.
The NJL
The classic elements of a scientific paper have tradition-
ally been the summary or abstract and the introduction
(why the research was done?), the methods (how was it
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done?), the results (what was found?), and the discussion
(what does it mean, strengths and weaknesses, and what
next?). The NJL broadly reflects this successful and fa-
miliar structure. Figure 1 provides an overview of the in-
formation stored in the NJL.
Each study funded by the NIHR programmes has a
unique project thread within the NJL. Figure 2 presents the
types of information available for an NIHR HTA-funded
study, the CRASH2 trial (a large randomised placebo con-
trolled trial among trauma patients with significant haem-
orrhage of the effects of an antifibrinolytic treatment on
death and transfusion requirement, www.journalslibrary.
nihr.ac.uk/programmes/hta/0630320). The CRASH 2 study
has been selected as it provides a particularly effective ex-
ample of the richness and diversity of project information
available through the NJL. Whilst not all projects will gen-
erate such a broad range of material, core information is
available for all funded studies. Each project thread contains
important details, including the chief investigator, cost, start
and completion date, and any registry information.
The core of the thread on each project includes
elements that are peer reviewed (e.g. background,
methods, main results), and material provided by re-
searchers that are not peer reviewed or are reviewed
elsewhere, for which the library has no editorial respon-
sibility (e.g. links to other journal publications). Links
to relevant information are provided under five head-
ings – project overview, background and research ques-
tions, methods, results and impact. Each heading will
now be described with examples provided from the
CRASH2 trial.
Project overview (‘summary’)
This includes project descriptions extracted from appli-
cations, plain English summaries of the research and
links to any previous studies associated with the project
(e.g. prior systematic reviews, pilot and feasibility stud-
ies). Most information is provided as a requirement for
NIHR-funded research. Links to the study’s own website
are also provided, where they exist. The CRASH2 trial,
for example, has its own website (www.crash2.lshtm.
ac.uk) and links to a plain English summary of the study
extracted from the application are provided.
Background and research questions (‘introduction’)
This section describes the problem and sets out the
research that has informed the question posed. It may
include a commissioning brief or the researchers’ justifi-
cation of the importance of the topic, supported by
existing research, such as systematic reviews, feasibility
or external pilots. All new research should undertake a
prior systematic appraisal of the literature, ensuring it is
informed by the best knowledge and does not duplicate
what is already known [1]. This section of the NJL there-
fore makes such supporting evidence transparent. Links
to relevant study documentation, such as participant
information sheets and descriptions of interventions, are
provided where appropriate. Links to relevant registries,
such as ClinicalTrials.gov, are also provided. The
CRASH2 trial project thread, for example, presents a
Cochrane review that informed the study, links to the
ClinicalTrials.gov registry and the United Kingdom Clin-
ical Trials Gateway, and a Patient Information Sheet.
Fig. 1 Overview of threaded, living publications provided in the NIHR Journals Library
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Methods
Study protocols should be freely available as they reveal
the initial intent of the research and facilitate quality
assurance by enabling comparisons of original study
outcomes with those ultimately reported [15, 27]. In
recent years, the NJL has published study protocols and
amendments with their justification and approvals, enab-
ling studies to be reconstructed at each time point. An
important element for trials is the statistical analysis
plan, which is included as soon as it becomes available.
In the case of evidence syntheses, appropriate statistical
models used in complex meta-analyses and appropriate
tools used for appraising study quality are included. The
CRASH2 trial project thread, for example, includes a
detailed protocol, a trial explanation, a statistical analysis
plan and a description of intervention, in which eligibil-
ity criteria, randomisation and treatments are clearly
set out.
Results
Results develop over the course of a study. Early results
may be no more than a record of recruitment rate or
study newsletters. Results of sub-studies or methodo-
logical spin-offs may be available before the main study
results. Links to the main results of a study are provided
when available via links to peer-reviewed journals and to
the full report when published in the NIHR programme’s
peer reviewed, online journal. The full study report is a
complete record of study findings, methods, literature
informing the study, lessons learned and an update of
the literature in light of the results. The CRASH2 trial,
for example, has generated numerous outputs, including
a full report and associated peer-reviewed articles, links
to which are provided on the project thread. Links are
also provided to a prognostic model and other know-
ledge products, including a podcast of trial results.
Providing access to study data is an important part of
transparent reporting, supporting systematic reviews and
meta-analyses, enabling further analysis on study data
and informing the design of further research [28, 29].
Supporting data sharing from completed studies requires
appropriate management including the protection of
trial participants, maintained data standards and effect-
ive management of access and data repositories [30].
Researchers are often reticent in making data available
even though data-sharing statements are now a requi-
rement for many journals [31, 32]. NIHR-funded re-
searchers have been obliged since 2014 to provide data
sharing statements when submitting their final report
and to share appropriately anonymised data if requested
by the NIHR. Data sharing statements are made publicly
available through the NJL. The CRASH2 trial, for ex-
ample, has uploaded raw data from the study onto the
Free Bank of Injury and Emergency Research Data
(freeBIRD) repository, links to which are provided on
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Fig. 2 Thread of information provided for the CRASH2 trial in the NIHR Journals Library. The links in this figure can be seen in Additional file 1
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practical policy to ensure that there is a clear route of
managed access to study data, which will improve the
usability and replicability of research.
Impact
Authors may comment on and interpret their own
results and ideally provide an updated systematic review
that places the study in its research context, as well as a
commentary on the implications of the results for
patients, the NHS, health and social care. In some cases,
studies will have proceeded unexpectedly and may not
have been completed as planned. Accounts of such
studies have an important place in the NJL as they may
provide important lessons for other researchers and
research funders. In all cases, there will be an opportun-
ity for readers to respond to reports and to open a
discussion.
The life of a project does not end with the publication
of the final report, but extends to follow-on research,
systematic reviews and meta-analyses, as well as uptake
in clinical guidelines, other indicators of impact, or dis-
semination activities aiming to increase the likelihood of
translation and uptake. The NJL showcases available evi-
dence of impact from completed research, e.g. influence
on organisations that provide guidelines and advice to
improve health and social care in the United Kingdom,
including the National Institute for Health and Care
Excellence (NICE) or the National Screening Committee.
The CRASH2 trial, for example, has generated a wide
range of impact activity including NICE Guidance, a
Cochrane podcast and a BBC News item, links to which
are provided on the project thread.
How is the library populated?
Material in the NJL is derived from various sources.
Parts of the NJL are populated from information created
as part of the project funding process. All research
commissioned and published in the NJL is managed
through the NIHR programmes’ own research manage-
ment systems, using a database that captures the
research data from the point of application through to
final publication. Research teams use the system to
record key information, including the host institution,
registry information, ORCiD iD, and publications in
other journals relating to their NIHR-funded research.
Peer review and editorial processes are also managed
through these systems. Researchers are contractually
obliged to notify NIHR programmes of relevant activities
such as proposed changes to protocols, unexpected
opportunities for methodological development and ap-
plication and early study publications. Unlike other data
repositories that rely on voluntarily submitted data from
research teams or harvesting data from other websites,
the NJL makes use of information already retained
through effective research management. This efficiency
results in low curation costs for NJL and makes the best
use of information submitted by NIHR-funded re-
searchers through contractual obligations.
Updated information on the database is extracted
nightly, transformed and submitted to the NJL in XML
format. Full reports published in the NIHR journals are
typeset into an XML-first process during the production
stage following copyediting. XML technology defines
and structures report content through tagging, providing
flexibility for journal content data by broadening the
range of delivery formats. XML supports the storing,
searching, managing and access of content, allowing the
NJL to respond to users’ emerging needs. At the point of
publication, the NJL uploads abstracts and copies of the
final report to PubMed, PubMed Europe, NCBI Book-
shelf and other indexing sites on behalf of the authors.
The NJL is a member of CrossRef and each full report is
assigned a DOI at publication stage.
Searching and exploring the library
The NJL homepage contains a search function allowing
users to search for a condition/research area, a named
researcher or other term. Once an area of interest has
been selected, it is possible to refine the search using a
range of criteria such as project status or Health
Research Classification System health category. Selecting
a specific project opens its own, unique project thread.
Project threads are created at the point at which NIHR
studies are contracted and are a ‘living’ resource in that
each thread is populated as the project develops. Users
can therefore return to specific projects and track
through their development in an open, transparent and
timely manner and receive alerts when a project is
updated and when a final report is published in the
relevant journal.
The NJL presents a ‘stacked’ view of study documents,
enabling users to ‘drill down’ to the level of information
required. Those wishing to access an overview of key
findings can select the plain English summary on the
project thread or access other knowledge products, such
as conference presentations, uploaded to the Results sec-
tion. Those requiring more information can retrieve the
peer-reviewed, open access full report. People wishing to
assess the quality and accuracy of reporting can down-
load the study protocol and the study report, enabling
comparisons to be made between initial study intentions
and reported results. Those wishing to access the data to
inform secondary analysis or meta-analysis can click on
the data-sharing link in the results section of the project
thread. Anyone wishing to review the outcomes from
the research can click on the impact examples provided.
The NJL supports the wider ambitions of ‘research on
research’ by providing open access to information on
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key stages in the funding and delivery of research. This
supports the NIHR’s Research on Research programme
as well as external academics and other users who can
interrogate the NJL to understand, enhance and assess
the quality of health research commissioning, design,
dissemination and impact.
Discussion, challenges and future ambitions
Developments in online publications have made it pos-
sible for relevant information on commissioned health
research to be shared in an accurate, timely and access-
ible manner. The NIHR takes advantage of this and its
distinctive position as a funder to push the boundaries
of publication and make research more accessible to par-
ticipants and users at every stage. The NJL presents a
model that brings together the concepts of ‘threaded’
and ‘living’ publication, providing links to relevant infor-
mation and materials relating to a specific study in a
way that evolves over the life of each study. This obvi-
ates a problem often associated with living publications
by retaining permanent versions of research through full
reports [25].
The NJL develops the concept of threaded publication
in other notable ways. Whilst much threaded-publication
activity has, to date, focused on trial reporting [18, 23, 24],
the NJL extends this to include information for all
NIHR-funded studies, including evidence syntheses, quali-
tative studies and other designs. Furthermore, the NJL
extends the information retained for each study beyond
the completion of the research to include evidence of im-
pact. Sharing impact information improves awareness of
the implications of research and strengthens the under-
standing of what makes a project impactful, benefiting
researchers, evidence-users and funders alike.
The NJL generates notable challenges. The creation of
online journals has resulted in increased scrutiny of pub-
lication costs and publication options of traditional jour-
nals [33]. In recent years, there has been a rapid increase
in the number of online open access journals [34]. Many
journals seek to ensure exclusivity of reporting by tying
authors into strict copyright arrangements. How such
journals and authors respond to a living publication
where some of the data may have been previously pub-
lished and whether they will support links to the NJL re-
mains to be seen. In the United Kingdom, the NJL may
require new ways of capturing information in support of
the Research Excellence Framework, an impact evaluation
that assesses the research of British higher education insti-
tutions [35]. The Research Excellence Framework is in-
formed heavily by assessments of research outputs, and
the NJL thus presents new opportunities for impact as-
sessment as publication threads may involve several out-
puts requiring appropriate weighting, and authorship may
be more diffuse than previously reported.
Other challenges include assessing how ‘alive’ the NJL
should be, since updating too frequently may risk the
inclusion of inaccurate or misleading information. Fur-
thermore, given that the uptake of findings after study
completion may be diffuse and occur after many years,
how should this information be collated in the long
term?
We also need to ensure that the NJL is presented in
ways that are transparent and understandable for all
evidence-user communities, including patients and the
public. Whilst the traditional publication format re-
sponds to academic interests, it is important to acknow-
ledge that different evidence-user communities require
diverse and appropriate knowledge products. These
products may include the NIHR Dissemination Centre’s
signals, webinars or tailored evidence summaries, often
co-produced with the relevant user groups. We will sup-
port and monitor such diverse dissemination activities
and products through the NJL. Finally, we acknowledge
the potential overlap with related activity in the United
Kingdom, including ResearchFish and OpenTrials, and
with Higher Education Institutions’ systems such as
PURE, and are making our information available to
them. Supporting these enterprises ensures consistency
of data entry and minimises the risk of duplicated effort
for the researchers we fund.
We recognise that the NJL is taking a novel approach
to sharing research information, necessitating ongoing
quality assessment, monitoring and evaluation, and re-
quiring further innovation and change over the coming
years. We will share learning from the delivery of NJL to
inform the reporting and dissemination activity of the
wider NIHR and other funders and publishers. The suc-
cess of the library will depend on effective partnerships
between the research community, who will upload mate-
rials, and the NIHR as research funder and publisher.
Some elements may prove unworkable, while others may
be rendered obsolete by future developments, or simply
lose value. However, it reflects NIHR’s determination to
remain at the forefront of research and its dissemination
and impact, and to continue to add value to research at
every level.
Conclusion
Transparent and timely access to relevant study infor-
mation is essential if findings from health research are to
be replicable and usable in practice. As a funder and
publisher of research, the NIHR is able to ensure that all
relevant information generated through the research it
funds is publicly available. The relaunched NJL is an ini-
tiative that provides a ‘thread’ of relevant documents in
a ‘living’ format. The resource requires new ways of
working and information sharing with the researcher
communities and it will take time for the NJL to reach
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its full potential. However, we anticipate that the NJL
will serve as an effective model for sharing up-to-date,
accurate information on all studies, maximising the re-
turn on investment and ensuring that the diverse inter-
ests of patients and the public, the scientific community,
and those who plan and deliver health and social care
services are effectively supported.
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